David N Durrheim
Overview
Explore the profile of David N Durrheim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
226
Citations
2171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andrus J, Durrheim D
Expert Rev Vaccines
. 2025 Mar;
24(1):173-174.
PMID: 40051046
No abstract available.
2.
Flint J, Housen T, Kirk M, Durrheim D
BMC Public Health
. 2025 Feb;
25(1):635.
PMID: 39962418
Background: Field Epidemiology Training Programs (FETPs) aim to develop a skilled public health workforce through applied competency-based learning. With 98 programs globally and over 20,000 graduates, these programs play a...
3.
White J, Vidler M, Murray P, Durrheim D
J Aging Soc Policy
. 2024 Dec;
36(6):1452-1471.
PMID: 39670864
The COVID-19 pandemic required residential aged care facilities (RACFs) to meet the high care needs of residents in the context of stringent public health measures and staffing pressures. Given the...
4.
Durrheim D
Commun Dis Intell (2018)
. 2024 Nov;
48.
PMID: 39566184
This editorial focuses on the instructive value of carefully investigated measles outbreaks with reference to the outbreak report, also published today in CDI (doi: /10.33321/cdi.2024.48.61), documenting an apparent measles secondary...
5.
Williamson K, Faddy H, Nicholson S, Stambos V, Hoad V, Butler M, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066455
Passive immunisation with normal human immunoglobulin (NHIG) is recommended as post-exposure prophylaxis (PEP) for higher-risk measles contacts where vaccination is contraindicated. However, the concentration of measles-specific antibodies in NHIG depends...
6.
Takashima Y, Aslam S, Evans R, Mariano K, Lee C, Wang X, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066454
Measles is the most contagious communicable disease, causing an estimated 5.5 million cases and more than 30,000 deaths in the Western Pacific Region (WPR) during 2000. Rubella infection in a...
7.
Durrheim D, Andrus J, Tabassum S, Githanga D, Kojouharova M, Talab N
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932428
No vaccine has been more effective in reducing disease burden, especially in preventing child deaths, than measles-containing vaccine. The return on investment makes measles-containing vaccine one of the most cost-effective...
8.
Hagan J, Crooke S, Gunregjav N, Sowers S, Mercader S, Hickman C, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932425
Mongolia experienced a nationwide measles outbreak during 1 March 2015-31 December 2016, with 49,077 cases reported to the WHO; many were among vaccinated young adults, suggesting a possible role of...
9.
Kaufman J, Rak A, Vasiliadis S, Brar N, Atif E, White J, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932421
Global measles cases are on the rise following disruptions to routine immunisation programs during the COVID-19 pandemic, with devastating consequences. According to the World Health Organization, the behavioural and social...
10.
Kaufman J, Tuckerman J, Bonner C, Durrheim D, Costa D, Trevena L, et al.
Hum Vaccin Immunother
. 2024 Jun;
20(1):2359623.
PMID: 38845399
Data on routine childhood vaccination coverage can only tell us who is under-vaccinated; it cannot explain why vaccine coverage is low. Collecting data on the reasons behind under-vaccination is necessary...